Business
Abattis annouces private placement
Abattis annouces private placement.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n \n Normal\n 0\n \n \n \n \n false\n false\n false\n \n EN-CA\n X-NONE\n X-NONE\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\nABATTIS ANNOUNCES\nPRIVATE PLACEMENT\n\n \n\n \n\n \n\nVancouver, BC ? March 4,\n2014 - Abattis Bioceuticals Corp. (the ?Company? or ?Abattis?) (OTC PINK:\nATTBF) (CSE: ATT), announces a proposed private placement of up to\n$2,000,000. \n\n \n\nUnder the terms of the Private Placement, Abattis will issue up to\n4,444,444 Units. Each Unit will consist of one Common Share at $0.45 per share,\n and one full Share Purchase\nWarrant. One Warrant will be exercisable\ninto one Common Share at a price of $0.50 per Common Share. The expiry date for the exercise of the\nWarrants will be 18 months after the closing of this Unit Offering. The Warrants will contain an acceleration\ncomponent whereby Abattis will have the right to call for the exercise of the\nWarrants if the Common Shares of the Company closes above $0.75 per share for a\nperiod of 10 conservative business days after the four month and one day hold\nperiod expires. \n\n \n\nProceeds of this offering will be used for acquisitions, joint venture\nopportunities, research and development, marketing, working capital and general\ncorporate purposes.\n\n \n\nThe Board of Directors of Abattis wishes to acknowledge the support of\ninvestors who have shown confidence in the business plan that Abattis is\nexecuting in this exciting new sector of the economy and capital markets. \n\n \n\n \n\nAbout Abattis\nBioceuticals Corp.\n\nAbattis is a specialty\nbiotechnology\ncompany with capabilities through its wholly owned\nsubsidiaries of cultivating, licensing and marketing\nproprietary\ningredients, bio-similar\ncompounds, patented equipment and consulting services to medicinal markets in North\nAmerica. The company is positioned to capitalize on the fast growing trend toward\nmarijuana legalization in the United States and for medicinal\nuse\nin Canada and\ninternational jurisdictions by\nsupplying and partnering with companies to employ its vertical cultivation systems, extraction equipment/technology, and strategic marketing support\nto licensed growers. The company also has an extensive pipeline of high-quality\nproducts and Intellectual Property\...